Unique ID issued by UMIN | UMIN000018032 |
---|---|
Receipt number | R000020629 |
Scientific Title | Initial use of Rotatable sphincterotome facilitates selective bile duct cannulation compared with use of conventional sphincterotome: a prospective randomized controlled trial of papillotome. |
Date of disclosure of the study information | 2015/08/01 |
Last modified on | 2018/12/24 00:57:19 |
Initial use of Rotatable sphincterotome facilitates selective bile duct cannulation compared with use of conventional sphincterotome: a prospective randomized controlled trial of papillotome.
Cannulation Study
Initial use of Rotatable sphincterotome facilitates selective bile duct cannulation compared with use of conventional sphincterotome: a prospective randomized controlled trial of papillotome.
Cannulation Study
Japan |
Of all diseases needed to perform ERC.
Medicine in general | Hepato-biliary-pancreatic medicine | Adult |
Others
NO
Initial use of rotatable sphincterotome facilitate common bile duct cannulation and reduce risk of post ERCP pancreatitis
Efficacy
Confirmatory
Pragmatic
Phase I,II
The primary endpoint is successful selective bile duct cannulation within 10 miniutes and 10 times after randomization.
The secondary endpoints are successful final selective bile duct cannulation rates, procedure success rate, selective bile duct cannulation time, number of attempts at bile duct cannulation, number of accidental pancreatic duct insertions, procedure time, radiation exposure time, use of precutting for selective bile duct cannulation, and complications including PEP rates in the randomized patients and also in the initially enrolled cohort.
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
YES
NO
Institution is not considered as adjustment factor.
YES
Central registration
2
Treatment
Medicine |
Rotatable shincterotome
Conventional sphincterotome
20 | years-old | <= |
Not applicable |
Male and Female
1. In patients with native papilla.
1. In patients with ECOG Perfoemance Status Grade 4.
2. In patients with impaired consciousness.
3. In patients with suspected pancreatobiliary maljunction.
4. In patients with previous gastrectomy with Billroth II or Roux-en-Y reconstruction.
5. In patients with acute pancreatitis
6. In patients with impacted stone or tumor of ampulla of Vater.
7. In patients with bilioduodenal fistula opening around the papilla
200
1st name | |
Middle name | |
Last name | Akira Kurita |
Kitano Hospital, The Tazuke Kofukai Medical Research Institute
Division of Gastroenterology and Hepatology, Digestive Disease Center
2-4-20 Ohgimachi, Kita-ku, Osaka 530-8480, Japan
06-6312-8831
kuritaaki1976@gmail.com
1st name | |
Middle name | |
Last name | Akira Kurita |
Kitano Hospital, The Tazuke Kofukai Medical Research Institute
Division of Gastroenterology and Hepatology, Digestive Disease Center
2-4-20 Ohgimachi, Kita-ku, Osaka 530-8480, Japan
06-6312-8831
kuritaaki1976@gmail.com
Kitano Hospital, The Tazuke Kofukai Medical Research Institute
None
Self funding
None
None
NO
田附興風会医学研究所北野病院(大阪府)
2015 | Year | 08 | Month | 01 | Day |
Unpublished
Completed
2015 | Year | 06 | Month | 15 | Day |
2016 | Year | 01 | Month | 01 | Day |
2018 | Year | 12 | Month | 20 | Day |
2018 | Year | 12 | Month | 20 | Day |
2018 | Year | 12 | Month | 20 | Day |
2018 | Year | 12 | Month | 31 | Day |
2015 | Year | 06 | Month | 22 | Day |
2018 | Year | 12 | Month | 24 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020629